Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-controlled study of roflumilast in hyperinflated COPD patients on LABA/LAMA therapy
2015-000053-21Phase 2Completed
- Sponsor
- FLUIDDA
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Roflumilast + LABA/LAMA with Placebo + LABA/LAMA (2 arms). Primary endpoint: Airway volume (iVaw). Started Apr 2015; status: completed.
02
Drugs
roflumilast
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2015-000053-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000053-21.